Chemical and microbiologic aspects of penems, a distinct class of β-lactams:: Focus on faropenem

被引:30
作者
Hamilton-Miller, JMT [1 ]
机构
[1] Royal Free & UCL, Sch Med, Dept Med Microbiol, London NW3 2PF, England
来源
PHARMACOTHERAPY | 2003年 / 23卷 / 11期
关键词
D O I
10.1592/phco.23.14.1497.31937
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many beta-lactam antimicrobials were developed between the 1960s and 1980s, with continuing development driven by the emergence of microbial resistance. Penems form a discrete class of beta-lactams that comprises structural hybrids of penicillins (penams) and cephalosporins (cephems). The chemistry and microbiology of the representative penems MEN 10700, ritipenem, CGP 31608, sulopenem, BRL 42715, and faropenem are reviewed. Particular emphasis is placed on faropenem, which is in late clinical development.
引用
收藏
页码:1497 / 1507
页数:11
相关论文
共 51 条
[1]  
AMYES AKB, 2002, 42 INT C ANT AG CHEM, pC1
[2]  
AMYES SGB, 2001, 1 INT M PEN CARB REL
[3]  
ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167
[4]  
*BAYER CORP, 2003, DAT FIL
[5]   CLINICAL AND BACTERIOLOGICAL EFFICACY AND TOLERABILITY OF FCE-22891 IN PATIENTS WITH EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
BOERSMA, WG ;
PUISTER, SMT ;
VANALTENA, R ;
DEVRIESHOSPERS, HG ;
MOLINARI, M ;
KOETER, GH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :872-875
[6]  
BRYSKIER A, 1995, EXPERT OPIN INV DRUG, V4, P705
[7]   Activities of faropenem, an oral β-lactam, against recent US isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis [J].
Critchley, IA ;
Karlowsky, JA ;
Draghi, DC ;
Jones, ME ;
Thornsberry, C ;
Murfitt, K ;
Sahm, DF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :550-555
[8]  
DALHOFF A, 2001, CLIN MICROBIOL INFEC, V7, pP1285
[9]   INVITRO ACTIVITY OF FCE-22101 AGAINST RESPIRATORY-TRACT PATHOGENS WITH REFERENCE TO PRODUCTION OF BETA-LACTAMASES [J].
DORNBUSCH, K ;
KRONVALL, G ;
GORANSSON, E ;
MORTSELL, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 :31-41
[10]   In vitro activity of faropenem against respiratory pathogens [J].
du Plessis, MN ;
Capper, TP ;
Klugman, KP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :575-577